RxSight, Inc. (RXST) Balance Sheet
As of 2026-06-30 (10-Q), RxSight, Inc. (RXST) reported total assets of $352.7M, total liabilities of $89.4M and shareholders' equity of $263.3M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $13.4M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
RXSTRxSight, Inc.Follow RXST — free
—
Price chart with a free account
- Market cap
- 208.8M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 3 Nov, in 10 days
| Line | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|
| Cash and equivalents | 24.4 | 11.8 | 9.7 | 16.7 | 19.9 | 13.4 | |
| Short-term investments | 135.0 | 94.0 | 117.5 | 220.5 | 208.2 | 195.4 | |
| Receivables | 4.9 | 11.0 | 20.3 | 30.1 | 23.4 | 18.5 | |
| Inventory | 8.0 | 14.8 | 17.4 | 22.0 | 31.6 | 37.1 | |
| Current assets | 176.3 | 134.6 | 168.4 | 293.8 | 287.5 | 327.4 | |
| Total assets | 192.7 | 150.2 | 182.6 | 318.6 | 311.8 | 352.7 | |
| Current liabilities | 11.1 | 17.2 | 20.9 | 25.9 | 26.3 | 80.4 | |
| Long-term debt | 39.8 | 40.2 | 0.0 | — | — | — | |
| Total liabilities | 54.5 | 60.3 | 22.2 | 37.3 | 36.1 | 89.4 | |
| Shareholders' equity | 138.2 | 89.9 | 160.4 | 281.2 | 275.7 | 263.3 |
USD millions · SEC XBRL
RxSight, Inc. — questions
- How much cash does RxSight, Inc. have?
- $13.4M in cash and cash equivalents as of 2026-06-30.
- What are RxSight, Inc.'s total assets?
- $352.7M as of 2026-06-30.
- What is RxSight, Inc.'s shareholders' equity?
- $263.3M as of 2026-06-30.
Every figure on this page comes from RxSight, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.